These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36265559)

  • 1. Diethyldithiocarbamate copper nanoparticle overcomes resistance in cancer therapy without inhibiting P-glycoprotein.
    Kang X; Wang J; Huang CH; Wibowo FS; Amin R; Chen P; Li F
    Nanomedicine; 2023 Jan; 47():102620. PubMed ID: 36265559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers.
    Chen W; Yang W; Chen P; Huang Y; Li F
    ACS Appl Mater Interfaces; 2018 Dec; 10(48):41118-41128. PubMed ID: 30444340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomimetic metal-organic nanoparticles prepared with a 3D-printed microfluidic device as a novel formulation for disulfiram-based therapy against breast cancer.
    Chang Y; Jiang J; Chen W; Yang W; Chen L; Chen P; Shen J; Qian S; Zhou T; Wu L; Hong L; Huang Y; Li F
    Appl Mater Today; 2020 Mar; 18():. PubMed ID: 34746366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.
    Wehbe M; Anantha M; Shi M; Leung AW; Dragowska WH; Sanche L; Bally MB
    Int J Nanomedicine; 2017; 12():4129-4146. PubMed ID: 28615941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly Stable, Coordinated Polymeric Nanoparticles Loading Copper(II) Diethyldithiocarbamate for Combinational Chemo/Chemodynamic Therapy of Cancer.
    Peng X; Pan Q; Zhang B; Wan S; Li S; Luo K; Pu Y; He B
    Biomacromolecules; 2019 Jun; 20(6):2372-2383. PubMed ID: 31117352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingomyelin-based PEGylation Cu (DDC)
    Liu H; Kong Y; Liu Z; Guo X; Yang B; Yin T; He H; Gou J; Zhang Y; Tang X
    Int J Pharm; 2022 Jun; 621():121788. PubMed ID: 35504431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elesclomol-Copper Nanoparticles Overcome Multidrug Resistance in Cancer Cells.
    Wang Q; Huang CH; Wibowo FS; Amin R; Shen J; Li F; Babu RJ
    ACS Appl Mater Interfaces; 2024 Mar; 16(11):13509-13524. PubMed ID: 38466024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of hepatocellular carcinoma with SP94 modified asymmetrical bilayer lipid-encapsulated Cu(DDC)
    Liu H; Kong Y; Liang X; Liu Z; Guo X; Yang B; Yin T; He H; Gou J; Zhang Y; Tang X
    Expert Opin Drug Deliv; 2023 Jan; 20(1):145-158. PubMed ID: 36462209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts.
    Han J; Liu L; Yue X; Chang J; Shi W; Hua Y
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):477-83. PubMed ID: 24060341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Old wine in new bottles: Advanced drug delivery systems for disulfiram-based cancer therapy.
    McMahon A; Chen W; Li F
    J Control Release; 2020 Mar; 319():352-359. PubMed ID: 31911155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.
    Dong X; Mattingly CA; Tseng MT; Cho MJ; Liu Y; Adams VR; Mumper RJ
    Cancer Res; 2009 May; 69(9):3918-26. PubMed ID: 19383919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomimetic nano-chelate diethyldithiocarbamate Cu/Fe for enhanced metalloimmunity and ferroptosis activation in glioma therapy.
    Wang R; Song W; Zhu J; Shao X; Yang C; Xiong W; Wang B; Zhao P; Chen M; Huang Y
    J Control Release; 2024 Apr; 368():84-96. PubMed ID: 38331004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activate the endogenous Cu
    Liang X; Li C; Yuan W; Ji M; Zhang J; Yan M; Lu Q; Gou J; Yin T; He H; Tang X; Zhang Y
    Int J Pharm; 2024 Mar; 652():123800. PubMed ID: 38218507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical Development.
    Wehbe M; Anantha M; Backstrom I; Leung A; Chen K; Malhotra A; Edwards K; Bally MB
    PLoS One; 2016; 11(4):e0153416. PubMed ID: 27055237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A polypeptide based podophyllotoxin conjugate for the treatment of multi drug resistant breast cancer with enhanced efficiency and minimal toxicity.
    Zhou H; Lv S; Zhang D; Deng M; Zhang X; Tang Z; Chen X
    Acta Biomater; 2018 Jun; 73():388-399. PubMed ID: 29694920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the accumulation of disulfiram and its copper complex in A549 cells using mass spectrometry.
    Lu X; Lin B; Xu N; Huang H; Wang Y; Lin JM
    Talanta; 2020 May; 211():120732. PubMed ID: 32070566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance.
    Patil YB; Swaminathan SK; Sadhukha T; Ma L; Panyam J
    Biomaterials; 2010 Jan; 31(2):358-65. PubMed ID: 19800114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes.
    Marengo A; Forciniti S; Dando I; Dalla Pozza E; Stella B; Tsapis N; Yagoubi N; Fanelli G; Fattal E; Heeschen C; Palmieri M; Arpicco S
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):61-72. PubMed ID: 30267751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfiram metabolites permanently inactivate the human multidrug resistance P-glycoprotein.
    Loo TW; Bartlett MC; Clarke DM
    Mol Pharm; 2004; 1(6):426-33. PubMed ID: 16028354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.